{"data":{"id":688,"lang":"en","title":"Brain Scans Reveal How Ketamine Rapidly Lifts Severe Depression by Reshaping Key Receptors","summary":"Japanese researchers used PET imaging to reveal how ketamine reshapes brain receptors to rapidly relieve treatment-resistant depression.","category":"science","category_label":"Science","published_at":"2026-03-10T04:01:52Z","updated_at":"2026-03-10T04:01:52Z","url":"https://techtools.cz/tools/news/article/688-brain-scans-reveal-how-ketamine-rapidly-lifts-severe-depression-by-reshaping","api_url":"https://techtools.cz/news-api/v1/articles/688?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/688.md?lang=en","image_url":"https://neurosciencenews.com/files/2026/02/ketamine-mental-health-depression-neuroscience.jpg","word_count":155,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260307213234.htm","domain":"sciencedaily.com"},{"url":"https://neurosciencenews.com/ketamine-depression-treatment-30212/","domain":"neurosciencenews.com"}],"translation":{"lang":"cs","id":702,"title":"Mozkové skeny odhalily, jak ketamin rychle zmírňuje těžkou depresi přestavbou klíčových receptorů","url":"https://techtools.cz/tools/news/clanek/702-mozkove-skeny-odhalily-jak-ketamin-rychle-zmirnuje-tezkou-depresi-prestavbou","api_url":"https://techtools.cz/news-api/v1/articles/702?lang=cs"},"content":"A team led by Professor Takuya Takahashi at Yokohama City University in Japan has used PET imaging to show for the first time how ketamine reshapes AMPA receptors — proteins critical for neuron communication — in specific brain regions tied to mood and reward. The study, published March 5 in Molecular Psychiatry, tracked 34 patients with treatment-resistant depression and 49 healthy controls who received intravenous ketamine or placebo over two weeks.\n\nThe scans revealed that ketamine triggers region-specific changes in AMPA receptor density: some cortical areas showed increased levels while reward-processing regions like the habenula showed reductions. These shifts correlated directly with symptom improvement, suggesting AMPAR dynamics are the mechanism behind ketamine's rapid antidepressant action.\n\nAbout 30% of people diagnosed with depression develop treatment-resistant forms that do not respond to conventional medications. The researchers say AMPAR PET imaging could become a biomarker to predict which patients will benefit from ketamine therapy, potentially personalizing treatment for millions worldwide."}}